The U.S. Food and Drug Administration (FDA) has recently denied an application for using MDMA, a promising psychedelic, to treat post-traumatic stress disorder (PTSD). PTSD affects about 13 million Americans. The FDA’s decision means that Lykos Therapeutics, the company behind the application, will need to conduct another large-scale study, which…
Copyright © 2023 Healthdomainmen.com [ [email protected] ]